Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

Publication | Open Access

DOI Full Paper Access

300

Citations

References

2014

Year

Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger, G. Luschin-Ebengreuth, Michael Knauer, Martin Moik, R. Jakesz, Michael Seifert, Susanne Taucher, Vesna Bjelic‐Radisic,

Annals of Oncology

Zoledronic AcidBreast OncologyEndocrine OncologyMedicinePharmacologyGynecologyBreast CancerPharmacotherapyAustrian BreastOncologyGynecology OncologyEndocrine-related CancerWomen's HealthOvarian CancerFinal Analysis